Global RBM requires interoperable architectures across EDC, IRT, eCOA, labs, imaging, EHR, and safety systems, but inconsistent CDISC/HL7 FHIR adoption and proprietary APIs impede near–real-time ...

In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date The ...

Clinical AI, a healthcare artificial intelligence company focused on modernizing clinical trial operations, today announced that MAIA(TM) Prescreening is now available on Google Cloud Marketplace, ...

When discussing the future of clinical trials, people often focus on the promise of exciting new technologies, including artificial intelligence (AI) and predictive modeling. However, even the most ...

Despite being a cornerstone of cancer treatment advancement, clinical trials remain inaccessible for many patients because of structural, socioeconomic, and systemic barriers. In this ...

Please provide your email address to receive an email when new articles are posted on . In our journey through academia, contract research organizations, big pharma and biotech startups, we have had ...

As clinical trials grow more complex, the technology infrastructure supporting them is under renewed scrutiny. Across data ...